MICVOTABART PELIDOTIN
UNII CEJ2UDF7TX

Substance Identification & Data

This profile provides standardized clinical and technical data for Micvotabart Pelidotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CEJ2UDF7TX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2867550-00-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
CEJ2UDF7TX
CAS Registry Number
2867550-00-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MICVOTABART PELIDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C200116
National Cancer Institute reference terminology for clinical and research data.
INN ID
13003
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
Micvotabart Pelidotin
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Micvotabart Pelidotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Micvotabart Pelidotin

Common Names & Synonyms

H-gamma1 heavy chain Homo sapiens (1-445) [VH (Homo sapiens IGHV3-23*01 (93.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.9] (26-33.51-58.97-105)) (1-116) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v81 CH2 C81 (CH1 R120>K (213) (117-214), hinge 1-15 (215-229), CH2 K81>C (230-339), CH3 E12 (355), M14 (357) (340-444), CHS K2>del (445)) (117-445)], (219-215')-disulfide with L-kappa light chain Homo sapiens (1'-215') [V-KAPPA (Homo sapiens IGKV3-20*01 (94.8%) -IGKJ1*01 (100%), CDR-IMGT [7.3.9] (27'-33'.51'-53'.90'-98')) (1'-108') -Homo sapiens IGKC*01 (99.1%) Km3 A45.1 (154'), V101 (192'), KCv93 K93>C (184') (109'-215')]; dimer (225-225'':228-228'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa; substituted at the sulfur atom of L-cysteinyl residues 289, 184', 289'' and 184''' with four (2S,5R,6R,7<sup>2</sup>S,10R,11S,14S,25S,28S,36<sup>3</sup>RS)-2-benzyl-11-[(2S)-butan-2-yl]-25-[3-(carbamoylamino)propyl]-6,10-dimethoxy-5,12,17,17-tetramethyl-4,8,13,16,19,24,27,30,36<sup>2</sup> ,36<sup>5</sup> -decaoxo-14,28-di(propan-2-yl)-20-oxa-3,12,15,18,23,26,29-heptaaza-1(2)-[1,3]thiazola-7(2,1),36(1)-dipyrrolidina-22(1,4)-benzenahexatriacontaphan-36<sup>3</sup> -yl (pelidotin) groups
immunoglobulin G1-kappa, anti-[Homo sapiens FN1 (fibronectin 1) extra domain B (ED-B) splice variant], Homo sapiens monoclonal antibody, conjugated through four cysteinyl residues to a derivative of auristatin
micvotabart pelidotin [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus